...

Will Simcock

BSc, Major in Neuroscience, Minor in Pharmacology

Will is a clinical neuroscientist currently studying his PhD investigating using rest-activity rhythms to predict treatment response in treatment resistant depression. His thesis is focused on utilising the objective tool actigraphy to evaluate early change during treatment with ketamine or ketamine + behavioural activation therapy, to improve patient and clinical outcomes.

With a passion for mood disorders and novel treatment and evaluation strategies, Will is building a strong foundation in his research with experience in both animal and clinical research. Alongside his personal research, Will works as a Research Assistant in the Department of Psychological Medicine at UOC, with a research focus in eating disorders in Māori and rangatahi.

With experience in animal labs, electrophysiology, drug administration and effects, clinical research, psychology, and statistical analysis, Will is establishing himself in a breadth of areas to develop his knowledge and skills as much as possible.

Qualifications
  • 2025-2028 PhD Candidate. Thesis: “In progress”, University of Otago, Christchurch, New Zealand
  • 2024-2025 First Class Honours in Neuroscience. Dissertation: “Ketamine Induces Alterations in Hippocampal Activity that Mimic a Biomarker in a Rat Model of Schizophrenia Risk”, University of Otago, Dunedin, New Zealand
  • 2020-2023 BSc, Major in Neuroscience, Minor in Pharmacology, University of Otago, Dunedin, New Zealand
Professional Interests & Specialist Areas
  • Clinical neuroscience
  • Psychological medicine
  • Novel antidepressant pharmaceuticals
  • Biotechnology for the evaluation of treatment response and illness course
  • Eating disorders – particularly in Māori and rangatahi
Find out more about Will Simcock